T1D at the Big Game!
Type 1 diabetes will be grabbing the spotlight this weekend! Nick Jonas will be in a commercial for Dexcom airing…
Evaluating Telemedicine: Connecting Patient Voice to Research
While “telemedicine” certainly existed prior to the COVID-19 pandemic, it was simply an option for patients who preferred it or…
OHSU Needs In Person Study Volunteers
IMPORTANT NOTE: In order to be considered for this study, you must live in proximity to the Oregon Health &…
Life with the DIY Loop
I’ve lived with type 1 diabetes for the past 20 years, and in that time frame, managing my diabetes has…
Weekly Coronavirus Resources for People with T1D – 8/21/2020
Everything you need to know this week about type 1 diabetes and coronavirus updates, in one easy-to-read place!
Weekly Coronavirus Resources for People with T1D – 8/14/2020
Everything you need to know this week about type 1 diabetes and coronavirus updates, in one easy-to-read place! Researchers, advocates,…
Weekly Coronavirus Resources for People with T1D – 8/14/2020
Everything you need to know this week about type 1 diabetes and coronavirus updates, in one easy-to-read place!
Weekly Coronavirus Resources for People with T1D – 7/03/2020
We’re going to take the opportunity to share out some critical resources each week that may help people get through this challenging coronavirus pandemic with the help of partners and experts.
Dexcom Launches Crucial Patient Assistance Program As Result of COVID-19 Pandemic
The COVID-19 pandemic has put immense pressure on both individuals with T1D, and the organizations who provide them with vital supplies and medications. While there’s no doubt that people with T1D face a more uncertain and risk-filled future as we navigate quarantine and social distancing, there have been some promising steps from several sides that have …
Continue reading “Dexcom Launches Crucial Patient Assistance Program As Result of COVID-19 Pandemic”
Diasome Announces Positive Results for HDV Insulin Additive to Manage Blood Sugar
Diasome Pharmaceuticals announced positive results this week from a Phase 2 study of its injectable hepatocyte directed vesicle (HDV) additive for insulin in patients with type 1 diabetes. The news could prove a major step forward for therapies that aim to improve and optimize the way insulin is used and metabolized by the body. In …
Continue reading “Diasome Announces Positive Results for HDV Insulin Additive to Manage Blood Sugar”
